UHS

UHS

USD

Universal Health Services Inc. Common Stock

$171.680-4.240 (-2.410%)

Preço em tempo real

Healthcare
Medical Care Facilities
Estados Unidos

Gráfico de preços

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$175.920

Máximo

$175.070

Mínimo

$170.355

Volume

0.01M

Fundamentos da empresa

Capitalização de mercado

11.3B

Setor

Medical Care Facilities

País

United States

Estatísticas de negociação

Volume médio

0.88M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $153.99Atual $171.680Máximo $243.25

Relatório de análise de IA

Última atualização: 26/04/2025
Gerado por IAFonte de dados: Yahoo Finance, Bloomberg, SEC

UHS: Universal Health Services Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: UHS Generate Date: 2025-04-26 10:03:41

Alright, let's break down what's been going on with Universal Health Services, ticker symbol UHS, and try to figure out what the picture looks like right now. Think of this as getting the lowdown on the stock's recent activity and the buzz around it.

Recent News Buzz: A Mixed Bag

The news flow for UHS lately has been a bit of a mixed bag, honestly.

On one hand, we saw Baird, an investment firm, pull back a bit on April 15th. They downgraded UHS from a "buy" equivalent (Outperform) to a "hold" equivalent (Neutral). Not only that, they chopped their price target – basically, where they think the stock should trade – from a pretty high $274 down to $224. That's a noticeable step back in their view.

But then, just a few days earlier, on April 9th, Guggenheim started covering the stock with a "Buy" rating and a $208 price target. And Morgan Stanley jumped in on March 26th with an "Equal-Weight" (another kind of "hold") rating and a $200 target.

So, you've got one firm getting less enthusiastic, while others are just starting coverage with ratings that aren't exactly screaming "sell." It tells you analysts have different views right now.

The other big piece of news is that UHS announced they'll be reporting their first-quarter earnings results soon after the market closes on April 23rd. Correction based on date: The earnings announcement was April 9th for results after market close on an unstated date. Given today's date is April 26th, the earnings call likely happened already or is imminent. This is a crucial event because it will give everyone a real look at how the company is actually performing. This earnings report is a major event. It's where the company shows its numbers, and that often dictates the stock's next big move, regardless of what analysts were saying beforehand.

Price Check: A Bumpy Ride Lately

Looking at the stock chart over the last month or so, it's been a bit of a rollercoaster. The price was hanging out in the $180s and even touched the low $190s back in late March/early April. Then, things took a noticeable dip around April 4th, dropping into the low $170s and even hitting a 52-week low of $153.99 on April 21st. Ouch.

Since hitting that low, though, the stock has bounced back somewhat. It closed yesterday (April 25th) around $171.68. So, it's recovered a bit from the absolute bottom but is still well off its recent highs and way down from its 52-week high of $243.25.

The AI prediction for the very near term? It sees a small uptick today (+0.53%), another tiny gain tomorrow (+0.06%), and then a slight dip the day after (-0.13%). This suggests the AI thinks the recent bounce might continue just a little bit before possibly leveling off or slightly pulling back.

Putting It Together: Outlook & Ideas

Based on the news, the price action, and the AI's short-term view, what does this picture suggest?

The analyst views are mixed, leaning cautious with the Baird downgrade, but the new coverage isn't outright negative. The price has taken a significant hit recently but is showing signs of trying to recover from its 52-week low. The AI sees a tiny bit more upward movement right now.

Considering all this, the apparent near-term leaning seems mixed to cautiously optimistic if the recent bounce holds. It's definitely not a clear "all systems go" buy signal, especially with the volatility and the recent downgrade.

  • Potential Strategy Idea (Cautious): If you were considering this stock, the recent dip brought it down significantly. The AI and the recent price action suggest a small bounce might be underway. The provided data points to potential entry areas around $172.50 to $173.44. The stock is currently right in that neighborhood. Entering here would be betting that the bounce continues, perhaps towards the AI's projected target price of $180.52 or the provided take-profit level of $177.46.
  • Managing Risk: Because the stock has been so volatile and recently hit a low, managing risk is key. The provided data suggests a potential stop-loss level at $156.58. This is just above the recent 52-week low, acting as a point to potentially exit if the price drops significantly again, limiting potential losses.

Remember, these are just potential ideas based on the data provided. The upcoming earnings report is the wild card that could change everything quickly.

Company Context: Healthcare Focus

It's worth remembering that Universal Health Services is a big player in the Healthcare sector, specifically running Medical Care Facilities like hospitals and behavioral health centers. This means their business is tied to trends in healthcare demand, insurance, and government policies. The fact that they have a relatively low P/E ratio (around 9.45) compared to the industry average (15.5x) could suggest it's undervalued based on earnings, but their high debt level is something to be aware of. The recent price drop might reflect broader concerns about the healthcare industry or company-specific issues that the upcoming earnings report might clarify.

Disclaimer: This analysis is for informational purposes only and is based solely on the provided data. It is not financial advice. Stock investing involves risk, and you could lose money. Always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Notícias relacionadas

Analyst Upgrades

Baird Downgrades Universal Health Services to Neutral, Lowers Price Target to $224

Baird analyst Michael Ha downgrades Universal Health Services from Outperform to Neutral and lowers the price target from $274 to $224.

Ver mais
Baird Downgrades Universal Health Services to Neutral, Lowers Price Target to $224
PR Newswire

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2025, after the market...

Ver mais
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
Analyst Upgrades

Guggenheim Initiates Coverage On Universal Health Services with Buy Rating, Announces Price Target of $208

Guggenheim analyst Jason Cassorla initiates coverage on Universal Health Services with a Buy rating and announces Price Target of $208.

Ver mais
Guggenheim Initiates Coverage On Universal Health Services with Buy Rating, Announces Price Target of $208
Analyst Upgrades

Morgan Stanley Initiates Coverage On Universal Health Services with Equal-Weight Rating, Announces Price Target of $200

Morgan Stanley analyst Craig Hettenbach initiates coverage on Universal Health Services with a Equal-Weight rating and announces Price Target of $200.

Ver mais
Morgan Stanley Initiates Coverage On Universal Health Services with Equal-Weight Rating, Announces Price Target of $200

Previsão de IABeta

Recomendação de IA

Altista

Atualizado em: 28/04/2025, 05:54

BaixistaNeutroAltista

58.1% Confiança

Risco e negociação

Nível de risco3/5
Risco médio
Adequado para
ValorConservador
Guia de negociação

Ponto de entrada

$171.36

Tomar lucro

$175.09

Parar perda

$154.49

Fatores-chave

DMI mostra tendência de baixa (ADX:7.9, +DI:6.0, -DI:7.0), sugerindo cautela
O preço atual está extremamente próximo do nível de suporte ($171.85), sugerindo forte oportunidade de compra
O volume de negociação é 9.6x a média (10,137), indicando pressão de compra extremamente forte
MACD -0.1275 está abaixo da linha de sinal -0.0927, indicando um crossover de baixa

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.